{
  "openalex_id": "W2048753593",
  "doi": "https://doi.org/10.1097/01.ju.0000155845.44729.ba",
  "title": "ANDROGEN MEDIATED REGULATION AND FUNCTIONAL IMPLICATIONS OF FKBP51 EXPRESSION IN PROSTATE CANCER",
  "abstract": "No AccessJournal of UrologyInvestigative Urology1 May 2005ANDROGEN MEDIATED REGULATION AND FUNCTIONAL IMPLICATIONS OF FKBP51 EXPRESSION IN PROSTATE CANCER PHILLIP G. FEBBO, MARK LOWENBERG, AARON R. THORNER, MYLES BROWN, MASSIMO LODA, and TODD R. GOLUB PHILLIP G. FEBBOPHILLIP G. FEBBO , MARK LOWENBERGMARK LOWENBERG , AARON R. THORNERAARON R. THORNER , MYLES BROWNMYLES BROWN , MASSIMO LODAMASSIMO LODA , and TODD R. GOLUBTODD R. GOLUB View All Author Informationhttps://doi.org/10.1097/01.ju.0000155845.44729.baAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Androgen ablation continues to be the most effective therapy for metastatic prostate cancer, although the biologically active androgen receptor (AR) target genes remain largely unknown. Because AR signaling continues in hormone refractory disease, effector AR target genes may have therapeutic import. Materials and Methods: We used oligonucleotide microarrays to identify genes with expression induced by androgen and associated with androgen independent growth. The androgen induced expression of FKBP51, a steroid receptor chaperone, was further investigated in LNCaP cells by Northern and Western analysis, and in primary prostate specimens using immunohistochemistry. We used stable clones over expressing FKBP51 to test the functional effects of FKBP51. Results: Many genes had expression that correlates with androgen stimulation in LNCaP cells but relatively few had reproducible, androgen mediated changes in expression across multiple prostate cancer cell lines. FKBP51 had androgen induced RNA and protein expression in LNCaP cells and decreased expression in normal prostate epithelial cells following castration. Further study demonstrated that FKBP51 induction was not a generalized response to cell proliferation, FKBP51 protein physically interacts with AR and LNCaP cells constitutively over expressing FKBP51 have increased ligand mediated AR activation of an exogenous AR reporter construct and endogenous prostate specific antigen. Conclusions: Taken together these results confirm FKBP51 as an androgen induced gene, demonstrate a physical interaction between FKBP51 and AR and suggest that FKBP51 over expression increases AR transcriptional activity in prostate cancer. References 1 : Studies on prostatic cancer. II. The effects of castration on advanced carcinoma of the prostate gland Arch Surg1941; 43: 209. Google Scholar 2 : A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med1989; 321: 419. Google Scholar 3 : The development of androgen-independent prostate cancer. Nat Rev Cancer2001; 1: 34. Google Scholar 4 : Cloning of human androgen receptor complementary DNA and localization to the X chromosome. Science1988; 240: 327. Google Scholar 5 : Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med1995; 332: 1393. Google Scholar 6 : Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res2001; 61: 3550. Google Scholar 7 : Molecular determinants of resistance to antiandrogen therapy. Nat Med2004; 10: 33. Google Scholar 8 : Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology2000; 141: 4107. Google Scholar 9 : The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology2003; 144: 2380. Google Scholar 10 : Gene expression correlates of clinical prostate cancer behavior. Cancer Cell2002; 1: 203. Google Scholar 11 : Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol1994; 12: 2634. Google Scholar 12 : Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene2000; 19: 1288. Google Scholar 13 : FKBP54, a novel FK506-binding protein in avian progesterone receptor complexes and HeLa extracts. J Biol Chem1993; 268: 24270. Google Scholar 14 : Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP. Carcinogenesis2001; 22: 1399. Google Scholar 15 : The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA2002; 99: 11890. Google Scholar 16 : Identification and validation of novel androgen-regulated genes in prostate cancer. Endocrinology2004; 145: 3913. Google Scholar 17 : Immunophilin chaperones in steroid receptor signalling. Curr Top Med Chem2003; 3: 1348. Google Scholar 18 : Hsp90 as a therapeutic target in prostate cancer. Semin Oncol2003; 30: 709. Google Scholar 19 : Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression. Exp Hematol2003; 31: 622. Google Scholar 20 : Synergistic action of prolactin (PRL) and androgen on PRL inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor. Mol Endocrinol2002; 16: 1696. Google Scholar From the Departments of Medical Oncology (PGF, ART, MB), Pathology (ML) and Pediatric Oncology (TRG), Dana-Farber Cancer Institute, Departments of Medicine (PGF, MB) and Pathology (ML), Brigham and Women's Hospital and Departments of Medicine (PGF, MB) and Pathology (ML), Harvard Medical School, Boston and Broad Institute of Massachusetts Institute of Technology and Harvard (TRG), Cambridge, Massachusetts, Department/Laboratory of Experimental Internal Medicine, Academic Medical Center (ML), Amsterdam, The Netherlands, and Howard Hughes Medical Institute (TRG), Chevy Chase, Maryland© 2005 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 173Issue 5May 2005Page: 1772-1777 Advertisement Copyright & Permissions© 2005 by American Urological Association, Inc.Keywordsgene, FKBP51gene expressionandrogen receptorprostatic neoplasmsprostateMetricsAuthor Information PHILLIP G. FEBBO Financial interest and/or other relationship with Med Panel. More articles by this author MARK LOWENBERG More articles by this author AARON R. THORNER More articles by this author MYLES BROWN Financial interest and/or other relationship with Novartis Pharmaceuticals. More articles by this author MASSIMO LODA Financial interest and/or other relationship with Novartis Pharmaceuticals. More articles by this author TODD R. GOLUB More articles by this author Expand All Advertisement PDF downloadLoading ...",
  "authors": [
    {
      "display_name": "Phillip G. Febbo",
      "id": "A5058375967",
      "orcid": "https://orcid.org/0000-0002-6496-4664",
      "institutions": [
        {
          "id": "I107606265",
          "display_name": "Broad Institute",
          "country_code": "US",
          "type": "nonprofit"
        },
        {
          "id": "I1283280774",
          "display_name": "Brigham and Women's Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I63966007",
          "display_name": "Massachusetts Institute of Technology",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "PHILLIP G. FEBBO"
    },
    {
      "display_name": "Mark Löwenberg",
      "id": "A5010429038",
      "orcid": "https://orcid.org/0000-0002-4975-9945",
      "institutions": [
        {
          "id": "I1283280774",
          "display_name": "Brigham and Women's Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I63966007",
          "display_name": "Massachusetts Institute of Technology",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I107606265",
          "display_name": "Broad Institute",
          "country_code": "US",
          "type": "nonprofit"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "MARK LOWENBERG"
    },
    {
      "display_name": "Aaron R. Thorner",
      "id": "A5050754309",
      "orcid": "https://orcid.org/0000-0002-9160-7881",
      "institutions": [
        {
          "id": "I63966007",
          "display_name": "Massachusetts Institute of Technology",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I107606265",
          "display_name": "Broad Institute",
          "country_code": "US",
          "type": "nonprofit"
        },
        {
          "id": "I1283280774",
          "display_name": "Brigham and Women's Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "AARON R. THORNER"
    },
    {
      "display_name": "Myles Brown",
      "id": "A5033532061",
      "orcid": "https://orcid.org/0000-0002-8213-1658",
      "institutions": [
        {
          "id": "I107606265",
          "display_name": "Broad Institute",
          "country_code": "US",
          "type": "nonprofit"
        },
        {
          "id": "I1283280774",
          "display_name": "Brigham and Women's Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I63966007",
          "display_name": "Massachusetts Institute of Technology",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "MYLES BROWN"
    },
    {
      "display_name": "Massimo Loda",
      "id": "A5071763026",
      "orcid": "https://orcid.org/0000-0001-9674-8379",
      "institutions": [
        {
          "id": "I63966007",
          "display_name": "Massachusetts Institute of Technology",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I107606265",
          "display_name": "Broad Institute",
          "country_code": "US",
          "type": "nonprofit"
        },
        {
          "id": "I1283280774",
          "display_name": "Brigham and Women's Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "MASSIMO LODA"
    },
    {
      "display_name": "Todd R. Golub",
      "id": "A5001449157",
      "orcid": "https://orcid.org/0000-0003-0113-2403",
      "institutions": [
        {
          "id": "I107606265",
          "display_name": "Broad Institute",
          "country_code": "US",
          "type": "nonprofit"
        },
        {
          "id": "I1283280774",
          "display_name": "Brigham and Women's Hospital",
          "country_code": "US",
          "type": "healthcare"
        },
        {
          "id": "I136199984",
          "display_name": "Harvard University",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I4210117453",
          "display_name": "Dana-Farber Cancer Institute",
          "country_code": "US",
          "type": "funder"
        },
        {
          "id": "I63966007",
          "display_name": "Massachusetts Institute of Technology",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "TODD R. GOLUB"
    }
  ],
  "publication_year": 2005,
  "publication_date": "2005-04-01",
  "type": "article",
  "cited_by_count": 99,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S30525748",
    "display_name": "The Journal of Urology",
    "issn_l": "0022-5347",
    "issn": [
      "0022-5347",
      "1527-3792"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310315671"
  },
  "volume": "173",
  "issue": "5",
  "first_page": "1772",
  "last_page": "1777",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2779723316",
      "display_name": "LNCaP",
      "level": 4,
      "score": 0.8309175
    },
    {
      "id": "C61367390",
      "display_name": "Androgen receptor",
      "level": 4,
      "score": 0.778957
    },
    {
      "id": "C2780192828",
      "display_name": "Prostate cancer",
      "level": 3,
      "score": 0.7225305
    },
    {
      "id": "C2777911890",
      "display_name": "Androgen",
      "level": 3,
      "score": 0.61764324
    },
    {
      "id": "C502942594",
      "display_name": "Cancer research",
      "level": 1,
      "score": 0.54391176
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.51786876
    },
    {
      "id": "C2780962315",
      "display_name": "Bicalutamide",
      "level": 5,
      "score": 0.4146514
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.35559875
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.3470406
    },
    {
      "id": "C134018914",
      "display_name": "Endocrinology",
      "level": 1,
      "score": 0.32286763
    },
    {
      "id": "C143998085",
      "display_name": "Oncology",
      "level": 1,
      "score": 0.32057077
    },
    {
      "id": "C71315377",
      "display_name": "Hormone",
      "level": 2,
      "score": 0.2456446
    }
  ],
  "topics": [
    {
      "id": "T10543",
      "display_name": "Prostate Cancer Treatment and Research",
      "score": 0.9998
    },
    {
      "id": "T11041",
      "display_name": "Ubiquitin and proteasome pathways",
      "score": 0.9754
    },
    {
      "id": "T11146",
      "display_name": "Hormonal and reproductive studies",
      "score": 0.9746
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1097/01.ju.0000155845.44729.ba",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T15:29:31.214425",
  "source_database": "OpenAlex"
}